After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024.
AGIO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Agios Pharmaceuticals Inc is $1.45B. A total of 0.97 million shares were traded on the day, compared to an average of 1.48 shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, AGIO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 28 BUYs and 30 SELLs from insiders. Insiders purchased 289,744 shares during that period but sold 187,018.
In the most recent transaction, FOUSE JACQUALYN A sold 10,722 shares of AGIO for 21.64 per share on Jan 24. After the transaction, the Director now owns 129,253 company shares. In a previous transaction on Jan 24, Goff Brian sold 7,635 shares at 21.64 per share. AGIO shares that Chief Executive Officer owns now total 49,436.
Among the insiders who sold shares, Jones Cecilia disposed of 1,886 shares on Jan 24 at a per-share price of $21.64. This resulted in the Chief Financial Officer holding 13,069 shares of AGIO after the transaction. In another insider transaction, Burns James William sold 1,708 shares at $21.64 per share on Jan 24. Company shares held by the Chief Legal Officer now total 30,378.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AGIO in the last 3 months, the mean price target is $40.17 with high estimates of $49.00 and low estimates of $28.00. In terms of 52-week highs and lows, AGIO has a high of $29.23 and a low of $19.80.
As of this writing, AGIO has an earnings estimate of $Edgio, Inc. per share for the current quarter. EPS was calculated based on a consensus of AGCO Corporation estimates, with a high estimate of $Adecoagro S.A. per share and a lower estimate of $Alamos Gold Inc..
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $15.87, while its Total Shareholder’s Equity was $1.29B.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.22.